Bacil Pharma Reports Q2 Standalone Net Loss of ₹0.98 Lakh
Bacil Pharma Ltd · Outcome · 14 Oct 2026, 9:41 pm
Bacil Pharma Reports Q2 Standalone Net Loss of ₹0.98 Lakh Bacil Pharma reported zero operational revenue for the quarter ended 30th Sep'26, generating ₹9.18 lakh in other income compared to ₹8.91 lakh in the previous quarter. On a standalone basis, net loss after tax narrowed to ₹0.98 lakh from a loss of ₹1.61 lakh in the quarter ended 30th Jun'26, while total comprehensive income stood at ₹15.29 lakh. Consolidated net loss widened to ₹7.22 lakh. For the half year ended 30th Sep'26, total income fell sharply to ₹18.09 lakh from ₹105.74 lakh YoY.
Original exchange filing (PDF)
More announcements from Bacil Pharma Ltd
- Intimation regarding execution of Agreement by Wholly Owned Subsidiary of the Company · 05 Nov 2026
- Un-Audited Financial Results for the Quarter and Half Yearly Ended 30th September, 2026 · 14 Oct 2026
- Intimation for resignation of Company Secretary · 09 Oct 2026
- Bacil Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/10/2026 ,inter alia, to consider and approve 1. Unaudited Financial Results .... · 14 Oct 2026
- Scrutinizers Report for the Annual General Meeting of the Company for FY 2025-2026 · 24 Sept 2026
- Outcome/Proceeding of Annual General Meeting of the Company · 23 Sept 2026
- Annual Report for the Financial Year 2025-2026 · 31 Aug 2026
- Notice of Annual General Meeting to be held on 23rd September, 2026 · 30 Aug 2026
